Werewolf Therapeutics to Present Data from Ongoing Phase 1/1

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Chicago , Illinois , United States , Watertown , American , Randi Isaacs , Josh Rappaport , Ellen Lubman , Justin Moser , American Society Of Clinical Oncology , Scientific Communications , Werewolf Therapeutics Inc , Exchange Commission , Globenewswire Inc , Company Contact , Honorhealth Research Institute , Company Or Werewolf Nasdaq , Clinical Oncology , Annual Meeting , Associate Clinical Investigator , Health Research Institute , Chief Medical , Non Hodgkin Lymphoma , Private Securities Litigation Reform Act ,